Top Story
Pear Therapeutics' digital insomnia therapeutic will put FDA's PreCert framework through its paces
CEO and President Dr. Corey McCann said that Somryst, a digital treatment for chronic insomnia and depression, is the first software as a medical device product to be submitted through the regulator's pilot pathway. 
Anthem, K Health team up on personalized primary care tool for members
At-home workout service Pivot exits stealth with $17M in support

Latest News

Mental health chatbot UpLift Health closes $1M seed funding
July 22, 2019
FDA sought new PreCert participants, cleared new digital health products and more during Q2 2019
July 19, 2019
Deals, program launches headline digital health payer news during Q2 2019
July 19, 2019
An overview of APAC’s healthtech landscape – the first half of 2019
July 19, 2019
Ping An Good Doctor to develop 'internet hospital' model with 50 hospitals in China
July 18, 2019
Phreesia's CEO hopes today's strong listing is 'blazing a trail' for 2019's remaining digital health IPOs
July 18, 2019
Cancer-focused tech startup Vine Health lands £1.2M in seed funding
July 18, 2019
Philips grows digital health portfolio with acquisition of patient tracking, triage company Medumo
July 18, 2019

More News

Special Projects

Focus on: The Future of Pharma
Focus on: Planning for Innovation
Focus on Patient Experience
Interoperability: Health IT's hardest problem is (finally) at an inflection point
How the consumerization of healthcare is changing the industry
Focus on: Aging and the Silver Tsunami
Senior citizens talking.